Literature DB >> 15326183

The structure of the N-terminal region of murine skeletal muscle alpha-dystroglycan discloses a modular architecture.

Damir Bozic1, Francesca Sciandra, Doriano Lamba, Andrea Brancaccio.   

Abstract

Dystroglycan (DG) is a cell surface receptor consisting of two subunits: alpha-dystroglycan, extracellular and highly glycosylated, and beta-dystroglycan, spanning the cell membrane. It is a pivotal member of the dystrophin-glycoprotein complex and is involved in a wide variety of important cellular processes such as the stabilization of the muscle fiber sarcolemma or the clustering of acetylcholine receptors. We report the 2.3-A resolution crystal structure of the murine skeletal muscle N-terminal alpha-DG region, which confirms the presence of two autonomous domains; the first finally identified as an Ig-like and the second resembling ribosomal RNA-binding proteins. Solid-phase laminin binding assays show the occurrence of protein-protein type of interactions involving the Ig-like domain of alpha-DG.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326183     DOI: 10.1074/jbc.C400353200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  C. elegans dystroglycan coordinates responsiveness of follower axons to dorsal/ventral and anterior/posterior guidance cues.

Authors:  Robert P Johnson; James M Kramer
Journal:  Dev Neurobiol       Date:  2012-07-27       Impact factor: 3.964

2.  O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function.

Authors:  Mauro Imperiali; Claudio Thoma; Ernesto Pavoni; Andrea Brancaccio; Nico Callewaert; Annette Oxenius
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  Expansion of divergent SEA domains in cell surface proteins and nucleoporin 54.

Authors:  Jimin Pei; Nick V Grishin
Journal:  Protein Sci       Date:  2017-02-13       Impact factor: 6.725

4.  Neural maintenance roles for the matrix receptor dystroglycan and the nuclear anchorage complex in Caenorhabditis elegans.

Authors:  Robert P Johnson; James M Kramer
Journal:  Genetics       Date:  2012-01-31       Impact factor: 4.562

5.  X-ray structure of the mature ectodomain of phogrin.

Authors:  Martín E Noguera; María E Primo; Jean Jakoncic; Edgardo Poskus; Michele Solimena; Mario R Ermácora
Journal:  J Struct Funct Genomics       Date:  2014-11-26

6.  A dystroglycan mutation associated with limb-girdle muscular dystrophy.

Authors:  Yuji Hara; Burcu Balci-Hayta; Takako Yoshida-Moriguchi; Motoi Kanagawa; Daniel Beltrán-Valero de Bernabé; Hülya Gündeşli; Tobias Willer; Jakob S Satz; Robert W Crawford; Steven J Burden; Stefan Kunz; Michael B A Oldstone; Alessio Accardi; Beril Talim; Francesco Muntoni; Haluk Topaloğlu; Pervin Dinçer; Kevin P Campbell
Journal:  N Engl J Med       Date:  2011-03-10       Impact factor: 91.245

7.  The structure of Leishmania mexicana ICP provides evidence for convergent evolution of cysteine peptidase inhibitors.

Authors:  Brian O Smith; Nichola C Picken; Gareth D Westrop; Krystyna Bromek; Jeremy C Mottram; Graham H Coombs
Journal:  J Biol Chem       Date:  2005-12-28       Impact factor: 5.157

8.  Recent advances in the molecular pathogenesis of dystonia-plus syndromes and heredodegenerative dystonias.

Authors:  Catharina Casper; Eirini Kalliolia; Thomas T Warner
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

9.  An immunological analysis of dystroglycan subunits: lessons learned from a small cohort of non-congenital dystrophic patients.

Authors:  Ernesto Pavoni; Francesca Sciandra; Giorgio Tasca; Roberta Tittarelli; Manuela Bozzi; Bruno Giardina; Enzo Ricci; Andrea Brancaccio
Journal:  Open Neurol J       Date:  2011-10-20

10.  Insertion of a myc-tag within α-dystroglycan domains improves its biochemical and microscopic detection.

Authors:  Simona Morlacchi; Francesca Sciandra; Maria Giulia Bigotti; Manuela Bozzi; Wolfgang Hübner; Antonio Galtieri; Bruno Giardina; Andrea Brancaccio
Journal:  BMC Biochem       Date:  2012-07-26       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.